Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Asthma Spacers Market Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Author: Aditya Deshmukh
by Aditya Deshmukh
Posted: Jul 11, 2020

Asthma is a chronic disease condition, in which the airways in lungs get swelled and narrowed due to production of extra mucus, which results in difficulty in breathing. Spacers are tube like devices, which are attached to inhalers and used for administering aerosolized medication. Spacers help medication to reach the diseased area of lungs with minimal contact with mouth and throat, which might cause irritations and mild infections. These spacers (with metered dose inhalers) are used for treating several respiratory diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD).

get the main link:https://www.coherentmarketinsights.com/ongoing-insight/asthma-spacers-market-3020

Increasing prevalence of respiratory diseases is expected to drive the global asthma spacers market growth over the forecast period. According to the World Health Organization (WHO), in 2017, around 65 million people suffered from moderate to severe chronic obstructive pulmonary disease (COPD), among which 3 million die every year. In 2016, National Jewish Health reported that due to incorrect handling of asthma inhalers it may lead to serious complication such as asthma attack, because medication will not reach to their lungs in required amount. To overcome these problems, doctors recommend to use spacers. These factors are responsible for driving the global asthma spacers market growth.

Flovent HFA asthma inhaler of Glaxo Smith Kline (GSK) can be used with asthma spacers for convenient treatment of asthma, such factors may increase need for asthma spacer, and is expected to boost the global asthma spacers market growth. Several organizations such as Asthma and Allergy foundation of America, Asthma Australia, and National Heart, Lung, and Blood Institute (NHLBI) in the U.S. have initiated several awareness programs such as Asthma and Allergy Awareness Campaigns, Asthma Awareness Session, and National Asthma Education and Prevention Program, respectively, for providing information about the causes and prevention of asthma, which created awareness among people about chronic and incurable diseases. Such initiatives are expected to propel the global asthma spacers market growth.

North America is expected to hold dominant position in the global asthma spacers market, followed by Europe, due to high prevalence of asthma in these regions. For instance, according to The Global Asthma Report 2018, highest prevalence of asthma (?20%) was witnessed in regions such as Europe, North America, and Latin America. The regions such as Indian subcontinent, Asia Pacific, and Eastern Mediterranean are expected to boost the global asthma spacers market growth over the forecast period with a prevalence (

About the Author

Qqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqq

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Aditya Deshmukh

Aditya Deshmukh

Member since: Jun 03, 2020
Published articles: 21

Related Articles